The Iowa Board of Pharmacy told Iowan activists they liked New Mexico’s medical marijuana program. Next month, the former director of the New Mexico Medical Cannabis Program is coming to Ames to speak!
Check it out:
Dear NORML members and supporters in Iowa,
Please see ISU NORML alert and c.v. for Dr. Jenison below.
Hosted by ISU NORML
Sunday, November 10, at 4:00 PM
Memorial Student Union
Iowa State University
Ames is on U.S. Highway 30, just west of Interstate 35.
Dr. Jenison is the former director of the New Mexico Medical Cannabis
Program (2007-2010) and the former chair of the Advisory Committee to the
New Mexico Medical Cannabis Program (2010-2013).
Dr. Jenison also helped to lobby for the legislation before it was
Below is Dr. Jenison’s Curriculum Vitae. Follow WeedPress on Facebook for coverage of the event.
STEVEN A. JENISON, M.D.
DATE OF BIRTH: August 20, 1953
PLACE OF BIRTH: Ames, Iowa, USA
MAILING ADDRESS: P.O. Box 482
Dixon, NM 87527-0482
PHYSICAL ADDRESS: County Road 63, Private Drive 1123, No. 8
Dixon, NM 87527-0482
PHONE: (505) 579-9679
EDUCATION: B.S. Iowa State University
Ames, Iowa, 1975
Majors: Zoology & Anthropology
Honors: Phi Beta Kappa
Phi Kappa Phi
M.D. University of Iowa
Iowa City, Iowa, 1981
Honors: Alpha Omega Alpha
PROFESSIONAL CERTIFICATION: Diplomate in Internal Medicine,
American Board of Internal Medicine
1985 – present
Diplomate in Infectious Diseases,
American Board of Internal Medicine
1992 – 2002
American Academy of HIV Medicine
MEDICAL LICENSURE: State of New Mexico
Private Consultant, Public Health Practice & Medical Education 1998 –
Market Farmer 2004 – present
Talon de Gato Farm, Dixon NM (www.talondegato.com)
New Mexico Department of Health: 1995 – 2010
Medical Director, Infectious Diseases Bureau, 1998 – 2004 &
Public Health Division, Santa Fe 2006 – 2010
Medical Director, Sexually Transmitted Diseases 2004 – 2006
& Reproductive Health Clinic, Albuquerque
Medical Director, HIV/AIDS/STD Section, 1995 – 1998
Public Health Division, Santa Fe
Medical Director, Medical Cannabis Program 2007 – 2010
University of New Mexico Health Sciences Center: 1991-1995
Assistant Professor, Division of Infectious Diseases, 1991 – 1995
Department of Medicine
Assistant Professor, Department of Microbiology 1991 – 1995
Member, Medical and Scientific Staff, UNM Cancer Center 1991 – 1995
Medical Director, HIV/AIDS and Infectious Diseases Clinic, 1993 – 1995
UNM Hospitals and Clinics
Clinical Associate Professor, Department of 2004 – present
University of Washington Academic Medical Center
& The Fred Hutchinson Cancer Research Center, Seattle: 1986-1991
Staff Scientist, Public Health Sciences Division, 1989 – 1991
Fred Hutchinson Cancer Research Center
Research Fellowship, Tumor Biology Program, 1986 – 1989
Fred Hutchinson Cancer Research Center
Clinical Fellowship, Division of Infectious Diseases, 1986 – 1989
Department of Medicine, University of Washington
University of North Carolina at Chapel Hill School of Medicine: 1981-1986
Research Fellowship, Division of Infectious Diseases, 1985 – 1986
Department of Medicine
Clinical Fellowship, Division of General Medicine and 1984 – 1985
Epidemiology, Department of Medicine
Medical Internship & Residency, Department of Medicine 1981 – 1984
University of Iowa College of Medicine, Iowa City:
Externship in Pathology, Department of Pathology 1978 – 1979
(one-year program in clinical pathology for
Nicholas A. Rango M.D. Leadership Award, National Alliance of State &
Territorial AIDS Directors, Washington, DC. May 6, 2008.
University of Iowa College of Medicine Distinguished Alumnus Award for
Service, Iowa City, IA. June 11, 1999.
“Gold Star” Award for volunteer services hosting visits of international
HIV policy makers, National Council for International Visitors,
Albuquerque NM, November 17, 2005.
University of New Mexico Regents’ Lectureship, 1994.
Young Faculty Research Award, Western Section of the American Federation
for Clinical Research & the Western Society for Clinical Investigation,
Carmel, CA. February 10, 1994.
RECENT CLINICAL ACTIVITIES:
Infectious Diseases Consultant providing care for New Mexico prison
inmates living with HIV/AIDS, New Mexico Corrections Department, 1996 –
2004; 2006 – 2010.
Clinic Physician, New Mexico Department of Health Sexually Transmitted
Diseases Clinic, Albuquerque & Santa Fe, NM, 2000 – 2010.
Clinic Physician, Southwest C.A.R.E. Center, the HIV/AIDS Health
Management Alliance serving northeastern New Mexico, Santa Fe, NM, 1996 –
CLINICAL CONSULTATION & GRANT REVIEW ACTIVITIES:
Member, Ryan White Part C (Title III) & AETC Objective Review Committees
(9 ORCs): April 2003; September 2003; July 2005; July 2006; July 2009;
December 2009; May 2010; March, 2011; March, 2012.
Clinical Consultant, HRSA Ryan White Part C Program Site Visit Teams (16
January 20 – 21, 2004; June 24 – 25, 2004; June 4 – 5, 2008; June 19 – 20,
2008; June 24 – 25, 2008; July 15 – 16, 2008; October 29 – 30, 2008; March
18 – 19, 2009; June 9 – 10, 2009; June 11 – 12, 2009; June 23 – 24, 2009;
June 8 – 9, 2010; November 8 – 9, 2010; November 10 – 11, 2010; February
22 – 25, 2011; May 21 – 23, 2013. Ryan White Part A Consultant (3
visits): September 6 – 9, 2011; September 12 – 15, 2011; May 21 – 23,
2013. Ryan White Part D Consultant (1 site visit): September 16 – 18,
2013. Ryan White AETC Consultant & Team Leader: June 3 – 6, 2013.
Reviewer, California HIV/AIDS Research Program’s “HIV/AIDS
Patient-Centered Medical Home Demonstration Projects”, June 4 – 5, 2010.
Trainer, HIV/AIDS Bureau, HRSA: “Conducting Ryan White Clinical Care
Audits”, training for clinical consultants, Rockville MD, December 8,
Clinical Consultant, Academy for Educational Development, “Supporting
Networks of HIV Care” (3 consultations): Jackson MS, 2008; New Iberia LA,
2008; Honolulu HI, 2008.
Clinical Consultant, HealthHIV / CAEAR Foundation, “Supporting Networks
of HIV Care” & “Supporting Networks of HIV Care by Enhancing Primary
Medical Care” (20 programs): Ft. Lauderdale FL (Learning Community), 2005;
Dallas TX (Learning Community), 2005; San Antonio TX (Learning Community),
2006; Flagstaff AZ (HIV rapid testing), 2007; Ponca City, OK (HIV rapid
testing), 2009; Mt. Olive NC (HIV primary care), 2009; Tyler TX (HIV
primary care), 2009; Houston TX (HIV rapid testing), 2009; Los Angeles CA
(HIV primary care), 2010; Buffalo NY (HIV rapid testing) 2010; Anderson IN
(HIV primary care), 2010; Seattle WA (HIV Program Administration), 2010;
Alpine CA (HIV rapid testing & HIV primary care), 2010. “HIV Primary Care
Plus”: Seattle, WA; Bellingham WA; Las Vegas NV, 2010 – 2012; “National
Center for HIV Care in Minority Communities”: on-site trainings in Los
Angeles CA, Brawley / El Centro CA, Houston TX, Chicago IL, 2012.
Clinical Consultant, National Minority AIDS Council: update & revision of
educational materials on HIV & hepatitis co-infection in incarcerated
Member, Ad Hoc Scientific Review Committee of the National Cancer
Institute to evaluate research proposals regarding HIV associated
malignancies, Rockville, MD, 1995.
LEGISLATIVE ACTIVITIES – NEW MEXICO:
Senate Bill 12 (2010) – Amending the NM HIV Test Act to permit more
effective implementation of HIV Partner Services – enacted
House Bill 397 (2009): Providing for court-ordered treatment or isolation
until completion of therapy for persons deemed to pose a risk of
tuberculosis transmission to members of the public, relapse or development
of therapy-resistance – enacted.
Senate Bill 523 (2007): Enacting the Lynn & Erin Compassionate Use Act,
allowing the medical use of cannabis and the licensing of cannabis
production for medical use – enacted.
Senate Bill 270 (2007): Allowing HIV testing during routine medical care
with patient consent but without a requirement for pre-test counseling,
and providing for the option to decline testing – enacted.
Senate Bill 805 (2003): Allowing routine HIV testing during pregnancy with
patient consent but without a requirement for pre-test counseling, and
providing for the option to decline testing – enacted.
House Bill 812 (2001): Allowing syringe sales in pharmacies without a
prescription – enacted.
House Bill 813 (2001): Limiting the liability of any person who
administers opiate antagonist medications to treat suspected drug overdose
House Bill 276 (2000): Amending the New Mexico HIV Test Act to allow
health care workers, law enforcement officers and correctional officers to
petition the court to obtain HIV testing on source individuals when
consent is not obtained – enacted.
Senate Bill 220 (1997): Enacting the New Mexico Harm Reduction Act,
mandating statewide syringe exchange programs to reduce blood borne
pathogen transmission among injection drug users – enacted.
Senate Bill 917 (1997): Amending the New Mexico HIV Test Act to allow
implementation of name-based HIV reporting – enacted.
Senate Bill 91 (1996): Amending the New Mexico HIV Test Act to allow
testing of individuals accused of sexual assault by court order when
consent is not obtained – enacted.
OTHER PROFESSIONAL EXPERIENCE:
Member, Board of Directors, New Mexico Medical Insurance Pool, 2012 –
Member, Medical Advisory Committee, New Mexico HPV / Pap Test Registry,
New Mexico Cancer Center, UNM Health Sciences Center, 2007 – present.
Chair, Medical Advisory Committee to New Mexico Department of Health
HIV/AIDS Medications Program (ADAP), 2005 – 2010.
Chair, Medical Advisory Board to the New Mexico Medical Cannabis Program,
2010 – 2013.
Member, New Mexico Governor’s Commission on HIV/AIDS (formerly Governor’s
Task Force on HIV/AIDS), 1995 – 2010.
Member, New Mexico Governor’s Drug Policy Advisory Group, June – December
Mentor to Jeffrey M. Marshall, New Mexico Governor’s Internship Program,
Member, Organizing Committee, “Working Together for Better Outcomes: New
Strategies for Dealing with Drug and Alcohol Abuse and Drug-Related Crime”
Conference, Albuquerque, NM, December 11 – 12, 2000.
Member, Advisory Committee to the National Institutes of Health & the
Centers for Disease Control to develop the Ribavirin Early Intervention
Trial for Hantavirus Pulmonary Syndrome, Atlanta, GA. January 12 – 13,
Member, University of New Mexico Biomedical Sciences Graduate Committees
1) Cheri Peyton Master’s Thesis: “Identification of Novel Human
Papillomaviruses in Cervical Specimens”. 1992 – 1994.
2) William Hays M.D. / Ph.D. candidate. “Characterization of the
cytosolic beta-glucosidase isolated from guinea pig liver.” 1994 – 1997.
Medical Consultant, New Mexico HIV/AIDS InfoNet Project (an HIV/AIDS
treatment advocacy resource funded by the National Library of Medicine),
Invited Participant, Forum for Collaborative HIV Research Report on the
Dissemination and Evaluation of Clinical Practice Guidelines for HIV.
Washington DC, May 11 – 12, 1998.
Invited Participant, “Management of Viral Hepatitis in Correctional
Settings”, Centers for Disease Control & Prevention, San Antonio, TX,
January 25 –26, 2003.
Invited Participant, “Management of Viral Hepatitis in Jails”, Centers for
Disease Control & Prevention, Atlanta, GA, July 14 – 15, 2003.
Member, Organizing Committee, “Ethics in HIV Care” Conference, presented
by the Institute for Ethics & New Mexico AIDS Education and Training
Center, UNM Health Sciences Center, Albuquerque, NM, October 8, November 5
and December 3, 2004.
Consultant to “Physicians for Human Rights” on harm reduction programs in
international HIV prevention. Washington, D.C., March 11, 2005.
Invited Participant, Opioid Overdose Prevention Program Consultation
Meeting, New York State Dept. of Health AIDS Institute, New York NY,
November 3, 2005.
Reviewer, Journal of Infectious Diseases & Clinical Infectious Diseases,
2002 – 2007.
COMMUNITY SERVICE ACTIVITIES AND AWARDS:
Member, Advisory Council, New Mexico Community AIDS Partnership, 2005 –
Recipient, Larry Peck Memorial Award from Networking New Mexico, a
statewide organization of people affected by HIV/AIDS, April 15, 1999.
Recipient, Distinguished Service Award, Eighth Annual “Circle of Harmony”
Native American HIV/AIDS Wellness Conference, March 22, 2007.
Member, Board of Directors, AID & Comfort of New Mexico (a charitable
organization that raises funds to defray medical costs of people living
with HIV), 1998 – 2002.
Member, Board of Directors, Santa Fe Cares (a charitable organization that
raises funds to support HIV/AIDS services in northern New Mexico), 2000 –
Member, Community Advisory Board, MPower Albuquerque (an HIV prevention
research project of the University of California at San Francisco Center
for AIDS Prevention Studies), 1997 – 2000.
Consultant, Archdiocesan Commission on HIV/AIDS, Archdiocese of Santa Fe,
Member, Community Advisory Board, Almas de Amistad (a substance use
treatment program for women), Albuquerque, NM, 2002 – 2004.
Member and President, Board of Directors, Dixon Cooperative Market, 2011 –
Volunteer Field Recorder, Mesa Prieta Petroglyph Project, 2012 – present
San Isidro Award as “Farmer of the Year”, Celebrando Las Acequias 2011.
Representative of the University of New Mexico to the XVIII Pacific
Science Congress, Beijing, People’s Republic of China, 1995; “Emergence of
Human Hantavirus Infections in North America”.
“Antibody Responses to Papillomavirus Infections”, International
Symposium on Human Papillomavirus, Ludwig Institute for Cancer Research,
São Paulo, Brazil. April 4 – 6, 1993.
“Reducing Health Disparities and Addressing the Determinants of Health in
HIV Care”, Keynote Address, Health Disparities & HIV Conference (sponsor:
AIDS Coalition for Education), Denver, CO, September 17, 2008.
“New Mexico Harm Reduction Programs”, plenary session presentation, C.D.C.
National Hepatitis Coordinator Conference, San Diego CA, May 25, 2000.
“HIV Health Management Alliances, HIV Prison Care, and Implementation of
Statewide Harm Reduction Programs in New Mexico”, opening plenary session
presentation, Southwestern Conference on Rural HIV/AIDS, National Rural
Health Association, Albuquerque NM, September 10, 1998.
“Development of Sin Nombre Hantavirus Serodiagnostic Assays”,13th
International Convocation on Immunology, SUNY, Buffalo, New York, June 1 –
“Sin Nombre Virus and the Hantavirus Pulmonary Syndrome”, Department of
Medicine Grand Rounds, U. of Iowa College of Medicine, June 10, 1999.
“HIV and Women”, 25th Annual Conference on Women’s Health Care, University
of Texas Southwestern Medical Branch, Dallas, TX, April 10, 2002.
“The Role of Harm Reduction Programs in HIV and Hepatitis Prevention”;
and, “Hepatitis C in Prisons”. Hepatitis C Clinical Update Conferences,
U. of Texas Southwestern Medical Center: Dallas TX, June, 2000; Dallas,
TX, June, 2002; Austin, TX, June, 2002; Dallas, TX, March, 2003; San
Antonio, TX, June, 2004.
“Hepatitis C as a Public Health Issue for Native Americans”. Workshop
Presentation at the National Forum on Health Disparity Issues for Native
American Indians and Alaska Natives, Office of Minority Health, Denver,
CO, September 25, 2002.
“Heroin Overdose Treatment & Prevention Initiatives in New Mexico”,
Northern California Regional Overdose Death Prevention Meeting, Ukiah, CA,
June 18, 2003.
“HIV Early Intervention and Treatment”, two full-day workshops facilitated
by the National Native American AIDS Prevention Center (NNAAPC) for the
Turtle Mountain Band of the Chippewa, Belcourt, ND, June 26 – 27, 2003.
“Statewide Implementation of Harm Reduction Programs in New Mexico”,
Plenary Presentation. 14th Texas HIV/STD Conference, Austin TX, December
“Heroin Overdose Prevention & Treatment in New Mexico”. Health Officers
Association of California Semiannual Conference, Riverside CA, May 6,
“Opiate Overdose Treatment: Program Implementation in New Mexico”. Opiate
Overdose Conference, Harm Reduction Coalition. New York NY, June 28, 2005.
“Policy Discussion – Impact & Implications”, 1st National Conference on
Methamphetamine, HIV & Hepatitis: Science & Response in 2005, Salt Lake
City, UT, August 19, 2005.
“HIV Primary Care” & “ABC Counseling in the Real World”. Wyoming
Reproductive Health Update, Region 8 Family Planning Ctr., Jackson Hole,
WY, May 21, 2006.
“STD Risk Assessment & Screening in Long-Haul Truck Drivers & Sex Workers,
New Mexico, USA: Implications for STD Prevention & Control in Highly
Mobile & Difficult to Reach Populations”. 2006 National STD Prevention
Conference, Jacksonville, FL, May 10, 2006.
“Medicine Grand Rounds – STDs & HIV Clinical Update” & “HIV for the Dental
Professional”, (for the Dakotas AIDS Education & Training Center), Sanford
School of Medicine, U. of South Dakota, Sioux Falls, SD, September 23,
“HIV Testing & Services in a Primary Care Setting”, Navajo Area Indian
Health Service Internal Medicine & Family Medicine Conference, Telluride
CO, March 7, 2010.
PRIOR RESEARCH SUPPORT:
Centers for Disease Control & Prevention, TS-1202:
“Sexually Transmitted Diseases Screening of Long Haul Truck Drivers”
Cooperative Agreement with the Association for Prevention Teaching &
Research. P.I.: Steven Jenison, M.D. 10/01/2003 – 9/30/2007
National Cancer Institute, R01 CA57975 02:
Antigenic Variability Among HPVs Involved in Genital Cancer
P.I.: Steven Jenison, M.D. 7/15/92 9/30/95
National Center for Allergy and Infectious Disease, R01 AI36336 01:
Sentinel Surveillance for Four Corners Hantavirus
P.I.: Brian Hjelle, M.D. 8/01/94 9/30/95
Centers for Disease Control and Prevention, “Hantavirus Surveillance and
Prevention”: Contract for performance of hantavirus diagnostic testing
with the New Mexico Department of Health. 1993 1995.
National Cancer Institute, K11 CA01391 05 (Physician Scientist Award)
Immune Responses to Human Papillomaviruses Involved in Genital Neoplasia.
P.I.: Steven Jenison, M.D. 7/1/89 6/30/94
National Institutes of Health, STD Training Grant, Post doctoral Research
Fellowship (Institutional Award: U. of Washington), 7/1/88 6/30/89.
American Social Health Association: Post doctoral Research Fellowship
(Individual Award), 7/1/86 6/30/88. U. of Washington
National Institutes of Health, Sexually Transmitted Diseases Training
Post doctoral Research Fellowship (Institutional Award: U. of North
Carolina at Chapel Hill), 7/1/85 6/30/86.
American Liver Foundation:
Post doctoral Research Fellowship (Individual Award), 7/1/84 6/30/85.
U. of North Carolina at Chapel Hill
1. Gage JC, Schiffman M Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler
CM & the New Mexico Pap Registry Steering Committee. Cervical
histopathology variability among laboratories. American Journal of
Clinical Pathology 139:330-335, 2013.
2. Valway S, Jenison S, Vega-Hernandez J, Keller N, Hubbard McCree D.
Sexually transmitted infection and hepatitis virus infection risk
assessment and screening among long-distance truck drivers traveling
through New Mexico, 2004-2006. American Journal of Public Health 99: 2063
– 2068, 2009.
3. Hubbard McCree D, Cosgrove S, Stratford D, Valway S, Jenison SA, Keller
N, Vega-Hernandez J. Sexual and drug use risk behaviors among long haul
truck drivers and their commercial sex contacts in New Mexico USA. Public
Health Reports 125: 52 – 60, 2010.
4. Jenison S, Yamada T, Morris C, Anderson B, Torrez Martinez N, Keller N,
Hjelle B. Characterization of human antibody responses to Four Corners
hantavirus infections among patients with hantavirus pulmonary syndrome.
Journal of Virology 68:3000 3006, 1994.
5. Yamada T, Wheeler CM, Halpern AL, Stewart A-CM, Hildesheim A, Jenison
SA. Human papillomavirus type 16 variant lineages in United States
populations characterized by nucleotide sequence analysis of the E6, L2,
and L1 coding segments. Journal of Virology 69:7743-7753, 1995.
6. Jenison SA, Yu X p, Valentine JM, Koutsky LA, Christiansen AM, Beckmann
AM, Galloway DA. Evidence of prevalent genital type human papillomavirus
infections in adults and children. Journal of Infectious Diseases 162:60
7. Hjelle B, Jenison S, Torrez Martinez N, Yamada T, Nolte K, Zumwalt R,
MacInnes K, Myers G. A novel hantavirus associated with an outbreak of
fatal respiratory disease in the southwestern United States: evolutionary
relationships to known hantaviruses. Journal of Virology 68:592 596, 1994.
8. Jenison SA, Lemon SM, Baker LN, Newbold JE. Quantitative analysis of
hepatitis B virus DNA in saliva and semen of chronically infected
homosexual men. Journal of Infectious Diseases 156:299 307, 1987.
9. Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between
heroin use, needle sharing and tattoos received in prison with hepatitis B
and C positivity among street-recruited injecting drug users in New
Mexico, USA. Epidemiology and Infection 127: 475-484, 2001.
10. Hjelle B, Jenison S, Torrez-Martinez N, Herring B, Quan S, Polito A,
Pichuantes S, Yamada T, Morris C, Elgh F, Lee HW, Artsob H, Dinello R.
Rapid and specific detection of Sin Nombre virus antibodies in patients
with hantavirus pulmonary syndrome by a strip immunoblot assay suitable
for field diagnosis. Journal of Clinical Microbiology 35:600-608, 1997.
11. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. Human papillomavirus
type 16 sequence variants: identification by E6 and L1 lineage-specific
hybridization. Journal of Clinical Microbiology 35: 11-19, 1997.
12. Jenison SA, Firzlaff JM, Langenberg A, Galloway DA. Identification of
the immunoreactive antigens of human papillomavirus type 6b using
Escherichia coli expressed fusion proteins. Journal of Virology 62:2115
13. Yamada T, Hjelle B, Lanzi R, Morris C, Anderson B, Jenison S. Antibody
responses to Four Corners hantavirus infections in the deer mouse
(Peromyscus maniculatus): identification of an immunodominant region of
the viral nucleocapsid protein. Journal of Virology 69:1939-1943, 1995.
14. Jenison SA, Yu X p, Valentine JM, Galloway DA. Human antibodies react
with an epitope of the HPV 6b L1 ORF which is distinct from the type
common epitope. Journal of Virology 63:809 818, 1989.
15. Green W, Feddersen R, Yousef O, Behr M, Smith K, Nestler J, Jenison S,
Yamada T, Hjelle B. Tissue distribution of hantavirus antigen in naturally
infected humans and deer mice. Journal of Infectious Diseases 177:
16. Firzlaff JM, Kiviat NB, Beckmann AM, Jenison SA, Galloway DA.
Detection of human papillomavirus capsid antigens in various squamous
epithelial lesions using antibodies directed against the L1 and L2 open
reading frames. Virology 164:467 477, 1988.
17. Jenison SA, Yu X p, Valentine JM, Galloway DA. Characterization of
human antibody reactive epitopes encoded by human papillomavirus types 16
and 18. Journal of Virology 65:1208 1218, 1991.
18. Zeitz PS, Graber JM, Voorhees RA, Kioski C, Shands LA, Ksiazek TG,
Jenison S, Khabbaz RF. Assessment of occupational risk for hantavirus
infection in Arizona and New Mexico. Journal of Occupational and
Environmental Medicine 39: 463-467, 1997.
19. Hjelle B, Chavez Giles F, Torrez Martinez N, Yamada T, Ascher M,
Jenison S. The dominant glycoprotein epitope of Four Corners hantavirus is
conserved across a wide geographic area. Journal of General Virology
20. Chu Y-K, Jennings G, Schmaljohn A, Elgh F, Hjelle B, Lee H-W, Jenison
S, Ksiazek T, Peters CJ, Rollin P, Schmaljohn CS. Cross-neutralization of
hantaviruses with immune sera from experimentally-infected animals and
from hemorrhagic fever with renal syndrome and hantavirus pulmonary
syndrome patients. Journal of Infectious Diseases 172:1581-1584, 1995.
21. Nerurkar VR, Song K J, Song J W, Nagle JW, Hjelle B, Jenison S,
Yanagihara R. Genetic evidence for a hantavirus enzootic in deer mice
(Peromyscus maniculatus) a decade before the recognition of hantaviral
pulmonary syndrome. Virology 204:563-568, 1995.
22. Hays WS, Jenison SA, Yamada T, Pastuszyn A, Glew RH. The primary
structure of the cytosolic beta-glucosidase of guinea pig liver.
Biochemical Journal 319:829-837, 1996.
23. Mandelson MT, Jenison SA, Sherman KJ, Valentine JM, McKnight B, Daling
JR, Galloway DA. The association of human papillomavirus antibodies with
cervical cancer risk. Cancer Epidemiology, Biomarkers & Prevention 1:281
24. Carter JJ, Yaegashi N, Jenison SA, Galloway DA. Expression of human
papillomavirus proteins in yeast Saccharomyces cerevisiae. Virology
182:513 521, 1991.
25. Yaegashi N, Jenison SA, Valentine JM, Dunn M, Taichman LB, Baker DA,
Galloway DA. Characterization of murine polyclonal antisera and monoclonal
antibodies generated against intact and denatured human papillomavirus
type 1 virions. Journal of Virology 65:1578 1583, 1991.
26. Yaegashi N, Jenison SA, Batra M, Galloway DA. Human antibodies
recognize multiple distinct type specific and cross reactive regions of
the minor capsid proteins of human papillomavirus types 6 and 11. Journal
of Virology 66:2008 2019, 1992.
27. Samuel MC, Bulterys M, Jenison S, Doherty P. Tattoos, incarceration
and hepatitis B and C among street-recruited injection drug users in New
Mexico, USA: update. Epidemiology and Infection 133: 1146-1148, 2005.
28. Goade DE, Bell R, Yamada T, Mertz GJ, Jenison S. Location of herpes
simplex virus type 2 (HSV-2) glycoprotein B (gB) epitopes recognized by
human serum immunoglobulin-G antibodies. Journal of Virology 70:2950-2956,
1. Hjelle B, Jenison SA, Goade DE, Green WB, Feddersen RM, Scott AA.
Hantaviruses: clinical, microbiologic and epidemiologic aspects. Critical
Reviews in Clinical Laboratory Sciences 32:469-508, 1995.
2. Jenison S, Hjelle B, Simpson S, Hallin G, Feddersen R, Koster F.
Hantavirus pulmonary syndrome: clinical, diagnostic, and virologic
aspects. Seminars in Respiratory Infections 10:259-269, 1995.
3. Galloway DA and Jenison SA. Characterization of the humoral response to
genital papillomaviruses. Molecular & Biological Medicine 7:59 72, 1990.
4. Hjelle B, Jenison S, Mertz G, Koster F, Foucar K. Emergence of
hantavirus disease in the southwestern United States. Western Journal of
Medicine 161:467-473, 1995.
5. Firzlaff JM, Hsia C N, Halbert CPL, Jenison SA, Galloway DA. Polyclonal
antibodies to human papillomavirus type 6 and 16 bacterially derived
fusion proteins. In “Cancer Cells, Volume 5: Papillomaviruses” eds. B.
Steinberg, J. Brandsma, L. Taichman. Cold Spring Harbor Press, Cold Spring
Harbor Laboratory, N.Y. pp105 113, 1987.
6. Foucar K, Nolte KB, Feddersen RM, Hjelle B, Jenison S, McLaughlin J,
Madar DA, Young SA, Zaki SR, Hughes L, McFeeley PJ, Simpson GL, Koster FT.
Outbreak of hantavirus pulmonary syndrome in the southwestern United
States: response of pathologists and other laboratorians, American Journal
of Clinical Pathology 101 (Suppl 1):S1 S5, 1994.
REPORTS & LETTERS:
1. Wilson C, Hjelle B, Jenison S. A probable case of hantavirus pulmonary
syndrome that occurred in New Mexico in 1975. Annals of Internal Medicine
2. Hjelle B, Jenison S, Torrez Martinez N, Damrow TA, and the Centers for
Disease Control and Prevention. Progress in development of hantavirus
diagnostic assays United States. Morbidity & Mortality Weekly Report
42:770 2, 1993.
3. Wolfe T, Amelunxen V, Torres D, Jenison S, Churchill J. Encouraging
pharmacy sale of syringes to injection drug users in New Mexico. Journal
of the American Pharmaceutical Association (Washington, D.C.) 42:S32-S34,
1. Jenison S, Hjelle B. Human immunodeficiency viruses and the acquired
immunodeficiency syndrome. In: Glew R & Ninomiya Y, eds. Clinical Studies
in Medical Biochemistry. 2nd edition. Oxford University Press, 1997.
2. Koster FT, Jenison S. The Hantaviruses (Chapter 254). In Gorbach SL,
Bartlett JG, & Blacklow NR (eds.): Infectious Diseases, Vol. 2.
Philadelphia, WB Saunders, 1998, pp. 2140-2147.
1. United States Patent No. 6,316,250 B1: Molecular Clones Producing
Recombinant DNA Antigens of the Hantavirus-associated Respiratory Distress
(HARDS). Issued 11-13-2001. Inventors: Brian Hjelle & Steve Jenison.
Assignee: University of New Mexico. Licensed to TriCore Reference
Laboratories, Albuquerque, NM.
2. United States Patent No. 6,197,497: Immunoassay for herpes simplex
virus. Issued 03-06-2001. Inventors: Diane Goade, Steve Jenison & Richard
Bell. Assignee: University of New Mexico.